New York-based biopharmaceutical company Emisphere Technologies has hired former Ernst and Young derivatives specialist Elliot Maza as chief financial officer. He will be responsible for leading the company's effort in financial operations, planning and corporate governance.
Source: Risk magazine | 02 Dec 2003
Updating your subscription status
Risk iPad and iPhone Apps